| IMR Stock | | | 1.14 0.02 1.72% |
Imricor Medical financial indicator trend analysis is infinitely more than just investigating Imricor Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imricor Medical Systems is a good investment. Please check the relationship between Imricor Medical Reconciled Depreciation and its Selling And Marketing Expenses accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imricor Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Imricor Medical Systems Reconciled Depreciation account and
Selling And Marketing Expenses. At this time, the significance of the direction appears to have totally related.
The correlation between Imricor Medical's Reconciled Depreciation and Selling And Marketing Expenses is 1.0. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Imricor Medical Systems, assuming nothing else is changed. The correlation between historical values of Imricor Medical's Reconciled Depreciation and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Imricor Medical Systems are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Reconciled Depreciation i.e., Imricor Medical's Reconciled Depreciation and Selling And Marketing Expenses go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Most indicators from Imricor Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imricor Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imricor Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10.1
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 3.9
M in 2024.
When running Imricor Medical's price analysis, check to
measure Imricor Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imricor Medical is operating at the current time. Most of Imricor Medical's value examination focuses on studying past and present price action to
predict the probability of Imricor Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imricor Medical's price. Additionally, you may evaluate how the addition of Imricor Medical to your portfolios can decrease your overall portfolio volatility.